The LUCENTE program involves both in-clinic and take home elements that together make up the total package. With over a 95% success rate, Lucente has been taking Europe by storm over the last year and a half.

 

The in-clinic component is a prescribed number of microneedling sessions utilizing our powerful LUCENTE serum to kick start the process of melanocyte inhibition and destruction.

 

Between microchanneling sessions, and for a period of time after the in-clinic portion of the treatment series has been provided, there will be a home cream used daily. 

 

The powerful combination of ingredients in LUCENTE attacks Melasma and PIH at four critical stages in the melanogenisis process, providing the most well-rounded approach currently available by any product, anywhere in the world.

 

The mix of both competitive and non-competitive blockers allows our unique formulation to:

 

1) Inhibit melanin formation

2) Inhibit/destroy melanosome formation and transfer

3) Exfoliate pigmented keratinocytes

4) Stabilize melanocyte activity via rich antioxidants

​

This program is a minimum of 3 months and can go up to 6 depending on the severity of the case.